David Laurence Becker
Founder at CoDa Therapeutics (NZ) Ltd.
Profile
David Laurence Becker is the founder of two companies.
In 2003, he founded CoDa Therapeutics (NZ) Ltd.
and holds the title of Director.
In 2005, he founded OcuNexus Therapeutics, Inc. Dr. Becker's current job is as a Director at Cell & Molecular Technologies, Inc.
David Laurence Becker active positions
| Companies | Position | Start |
|---|---|---|
Cell & Molecular Technologies, Inc.
 Cell & Molecular Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., Cell & Molecular Technologies, Inc. is a company that provides contract research, development services, and research products for biotech and pharmaceutical companies. The company is based in Phillipsburg, NJ. Cell & Molecular Technologies was acquired by Sentigen Holding Corp. on May 29, 1998 for $4.23 million. | Director/Board Member | - |
OcuNexus Therapeutics, Inc.
 OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA. | Founder | 2004-12-31 |
CoDa Therapeutics (NZ) Ltd.
 CoDa Therapeutics (NZ) Ltd. Pharmaceuticals: MajorHealth Technology CoDa Therapeutics (NZ) Ltd. develops and markets biopharmaceutical products. The company was founded by David Becker, Colin Green, Bradford J, Duft, and Howard E. Greene and on December 9, 2003 and is headquartered in Auckland, New Zealand. | Founder | 2003-12-08 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
OcuNexus Therapeutics, Inc.
OcuNexus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OcuNexus Therapeutics, Inc. develops and commercializes therapeutic products for wound care and tissue repair. The firm offers Nexagon, an oligonucleotide that downregulates the gap junction in tissue repair. Its Nexagon also reduces lesion spread, swelling, inflammation, scarring, and time to wound closure in various tissue types, including the eye, skin, spinal cord, nerve, and brain. The company was founded in 2005 by David Lawrence Becker, Colin C. Green and Bradford J. Duft and is headquartered in San Diego, CA. | Health Technology |
Cell & Molecular Technologies, Inc.
Cell & Molecular Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Thermo Fisher Scientific, Inc., Cell & Molecular Technologies, Inc. is a company that provides contract research, development services, and research products for biotech and pharmaceutical companies. The company is based in Phillipsburg, NJ. Cell & Molecular Technologies was acquired by Sentigen Holding Corp. on May 29, 1998 for $4.23 million. | Commercial Services |
CoDa Therapeutics (NZ) Ltd.
CoDa Therapeutics (NZ) Ltd. Pharmaceuticals: MajorHealth Technology CoDa Therapeutics (NZ) Ltd. develops and markets biopharmaceutical products. The company was founded by David Becker, Colin Green, Bradford J, Duft, and Howard E. Greene and on December 9, 2003 and is headquartered in Auckland, New Zealand. | Health Technology |
- Stock Market
- Insiders
- David Laurence Becker
